Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors
Interview with Arvind Dasari, MD, author of Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Oncology Author Interviews","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/jamaoncologyauthorinterviews\/Incidence_Prevalence_and_Survival_Outcomes_in_Patients_With_Neuroendocrine_Tumors_JAMA_Oncology.mp3?dest-id=422099","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/944d40-4d29-02d2-5a6083_800.png"},"title":"Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors","link":"javascript:;","id":"item-438007"}]
